A contribution to safety assessment of veterinary drug residues: In vitro/ex vivo studies on the intestinal toxicity and transport of covalently bound residues

Xenobiotica

Volumn 29, Issue 6, 1999, Pages 641-654

  Klee, S ^a   Baumung, I ^a   Kluge, K ^a   Ungemach, F R ^b   Horne, E ^a   O'Keeffe, M ^b   De Angelis, I ^a   Vignoli, A L ^a   Zucco, F ^d   Stammati, A ^c  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b ASHTOWN FOOD RESEARCH CENTRE   (Ireland)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FURAZOLIDONE; HYDROCHLORIC ACID; PRONASE; VETERINARY DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; COVALENT BOND; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG SAFETY; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; INTESTINE PERFUSION; LIVER MICROSOME; MALE; MONOLAYER CULTURE; NONHUMAN; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL SURVIVAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG RESIDUES; FURAZOLIDONE; GLUCOSE; HUMANS; INTESTINAL ABSORPTION; JEJUNUM; MALE; MICROSOMES, LIVER; RATS; RATS, WISTAR; SAFETY; VETERINARY DRUGS;

ANIMALIA;

EID: 0032813129     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982599238452     Document Type: Article

References (28)

1. BORENFREUND, E. and PUERNER, J., 1985, Toxicity determined in vitro by morphological alteration and neutral red absorption. Toxicology Letters, 24, 119 224.
2. DE ANGELIS, I., HOOGENBOOM, L. A. P., HUVENEERS-OORSPRONG, M. B. M., ZUCCO, F. and STAMMATI, A., 1994, Established cell lines for safety assessment of food contaminants: differing furazolidone toxicity to V79, HEp-2 and Caco-2 cells. Food and Chemical Toxicology, 32, 481-488.
3. DELIE, F. and RUBAS, W., 1997, A human colonic cell line sharing similarities with enterocytes as a model to examine oral absorption: advantages and limitations of the Caco-2 model. Critical Reviews in Therapeutic Drug Carrier Systems, 14, 221-286.
4. FISHER, R. B. and GARDNER, M. L. G., 1974, A kinetic approach to the study of solutes by isolated perfused small intestine. Journal of Physiology, 241, 211 234.
5. FOGH, J., FOGH, J. M. and ORFEO, T., 1977, One hundred and twenty seven cultured human tumor cell lines producing tumors in nude mice. Journal of the National Cancer Institute, 59, 221-226.
6. GRASSET, E., PINTO, M., DUSSAULX, E., ZWEIBAUM, A. and DESJEUX, J. F., 1984, Epithelial properties of human colonic carcinoma cell line Caco-2: electrical parameters. American Journal of Physiology, 247, C260-267.
7. GRASSET, E., BERNAREU, J. and PINTO, M., 1985. Epithelial properties of human colonic carcinoma cell line (Caco-2): effect of secretagogues. American Journal of Physiology, 248, C410-418.
8. GUENGERICH, F. P., 1989, Analysis and characterisation of enzymes. In W. Hayes (ed.), Principles and Methods of Toxicology (New York: Raven), pp. 784-785.
9. HOOGENBOOM, L. A. P., VAN KAMMEN, M., BERGHMANS, M. C. J., KOEMAN, J. H. and KUIPER, H. A., 1991, The use of pig hepatocytes to study the nature of protein-bound metabolites of furazolidone. Food and Chemical Toxicity, 29, 321-328.
10. HOOGENBOOM, L. A. P., BERGHMANS, M. C. J., POLMAN, T. H. G., PARKER, R. and SHAW, I. C., 1992, Depletion of protein-bound furazolidone metabolites containing the 3-amino-2-oxazolidinone side chain from liver, kidney, and muscle tissue from pigs. Food Additives and Contaminants, 9, 623-630.
11. HORNE, E., CADOGAN, A., O'KEEFE, M. and HOOGENBOOM, L. A. P., 1996, Analysis of protein-bound metabolites of furazolidone and furaltadone in pig liver by high-performance liquid chromatography with UV and mass spectrometric detection. Proceedings of the Euro Residue III Conference, 1, 510-515.
12. KLEE, S., UNGEMACH, F. R. and KROKER, R., 1992, Fate of furazolidone in the isolated perfused gut and in isolated intestinal cells. Acta Veterinaria Scandinavica, 87 (suppl.), 452-453.
13. KLUGE, K., KLEE, S. and UNGEMACH, F. R., 1996, Studies on the covalent binding of furazolidone to liver microsomes. Naunyn Schmiedeberg's Archives of Pharmacology, 253 (suppl.), R10.
14. LOWRY, O. H., ROSEBROUGH, N. J., FARR, A. and RANDALL, R. J., 1951, Protein measurements with the Folin reagent. Journal of Biological Chemistry, 193, 265-275.
15. MEUNIER, V., BOURRIE, M., BERGER, Y. and FABRE, G., 1995, The human intestinal epithelial cell line Caco-2; pharmacological and pharmacokinetic applications. Cell Biology and Toxicology, 11, 187-194.
16. PAUL, H. E. and PAUL, M. F., 1964, The nitrofurans - chemotherapeutic properties. In R. J. Schnitzer and F. Hawking (eds), Experimental Chemotherapy, vol. 2 (New York: Academic Press), pp. 307-370.
17. PINTO, M., ROBINE-LEON, S., APPAY, M. D., KEDINGER, M., TRIADOU, N., DUSSAULX, E., LACROIX, B., SIMON-ASSMAN, P., HAFFEN, K., FOGH, J. and ZWEIBAUM, A., 1983, Enterocyte-like differentiation and polarisation of the human colon carcinoma cell line Caco-2 in culture. Biology of the Cell, 47, 323-330.
18. RANALDI, G., ISLAM, K. and SAMBUY, Y. 1992, Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents. Antimicrobial Agents and Chemotherapy, 36, 1374-1381.
19. RICHTER, E. and STRUGALA, G. J., 1985, An all-glass perfusator for investigation of the intestinal transport and metabolism of foreign compounds in vitro. Journal of Pharmacological Methods, 14, 297-304.
20. RICO, A. G. and BURCAT-SACAZE, V., 1984, Toxicological significance of covalently bound residues. Food Additives and Contaminants, 1, 157-161.
21. TATSUMI, K., NAKABEPPU, H., TAKAHASHI, S. and KITAMURA, S., 1984, Metabolism in vivo of furazolidone: evidence for formation of an open-chain carboxylic acid and ketoglutaric acid from the nitrofuran in rats. Archives of Biochemistry and Biophysics, 234, 112-116.
22. VILIM, A., 1990, Definition of bound residues. Drug Metabolism Reviews, 22, 591-593.
23. 14C-furazolidone in piglets upon oral administration during 10 days and its interaction with tissue macromolecules. Food Additives and Contaminants, 3, 331-346.
24. VROOMEN, L. H. M., BERGHMANS, M. C. J., HEKMAN, P., HOOGENBOOM, L. A. P. and KUIPER, H. A., 1987a, The elimination of furazolidone and its open-chain cyanoderivative from adult swine. Xenobiotica, 17, 1427-1435.
25. VROOMEN, L. H. M., GROTEN J. P., VAN MUISWINKEL, K., VAN VELDHUIZEN, A. and VAN BLADEREN, P.J., 1987b, Identification of a reactive intermediate of furazolidone formed by swine liver microsomes. Toxicology In vitro, 1, 97-104.
26. VROOMEN, L. H. M., BERGHMANS, M. C. J., VAN BLADEREN, P.J., GROTEN J. P., WISSINK, C. J. and KUIPER, H. A., 1990, In vivo and in vitro metabolic studies of furazolidone: a risk evaluation. Drug Metabolism Reviews, 22, 663-676.
27. WEBER, N. E., 1992, Bound residues - safety testing and risk assessment. In H. A. Kuiper and L. A. P. Hoogenboom (eds), Proceedings of the Workshops, Ghent, 22-24 May 1992 and Thessaloniki, 30-31 October 1992 (Wageningen: State Institute for Quality Control of Agricultural Products (RIKILT-DLO)).
28. WENTGES, H., KLEE, S., UNGEMACHI, F. R. and POSPISCHIL, A., 1991, Influence of different solvents on the functionality and viability of the isolated perfused gut. Naunyn-Schmiedeberg's Archives of Pharmacology, 344 (suppl.), 33.